Interictal EEG Discharges, Reproductive Hormones, and Menstrual Disorders in Epilepsy

Annals of Neurology

Volumn 54, Issue 5, 2003, Pages 625-637

  Herzog, Andrew G ^a   Coleman, Anton E ^b   Jacobs, Alan R ^b   Klein, Pavel ^b   Friedman, Mark N ^b   Drislane, Frank W ^b   Ransil, Bernard J ^b   Schomer, Donald L ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ENZYME INDUCING AGENT; ESTRADIOL; FOLLITROPIN; GABAPENTIN; LUTEINIZING HORMONE; PHENYTOIN; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE; TESTOSTERONE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; ELECTROENCEPHALOGRAM; ENDOCRINE FUNCTION; EPILEPSY; EPILEPTIC DISCHARGE; FEMALE; GONADOTROPIN RELEASE; HEMISPHERIC DOMINANCE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENSTRUAL CYCLE; MENSTRUATION DISORDER; PREDICTION; PRIORITY JOURNAL; REPRODUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TEMPOROLIMBIC EPILEPSY;

ADOLESCENT; ADULT; ANTICONVULSANTS; BRAIN; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; FEMALE; FUNCTIONAL LATERALITY; GONADOTROPINS, PITUITARY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MENSTRUATION DISTURBANCES;

EID: 0242353074     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10732     Document Type: Article

References (72)

1. Martin JB, Reichlin S. Clinical neuroendocrinology. 2nd ed. Philadelphia: FA Davis, 1987:93-128.
2. Falconer MA, Serafetinides EA, Corsellis JAN. Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol 1964;10:233-48.
3. Engel J, Williamson PD, Wieser H-G. Mesial temporal lobe epilepsy. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive textbook. 1st ed. Philadelphia: Lippincott-Raven, 1998:2417-2426.
4. Sperling MR, Pritchard PB, Engel J, Daniel C, Sagel J. Prolactin in partial epilepsy: an indicator of limbic seizures. Ann Neurol 1986;20:716-722.
5. Wyllie E, Luders H, MacMillan JP, Gupta M. Serum prolactin levels after epileptic seizures. Neurology 1984;34:1601-1604.
6. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol 1986;43:341-346.
7. Drislane FW, Coleman AE, Schomer DL, et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology 1994;44:306-310.
8. Herzog AG. A hypothesis to integrate partial seizures of temporal lobe origin and reproductive endocrine disorders. Epilepsy Res 1989;3:151-159.
9. Bilo L, Meo R, Valentino R, et al. Abnormal patterns of luteinizing hormone pulsatility in women with epilepsy. Fertil Steril 1991;55:705-711.
10. Herzog AG. A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy. Neurology 1993;43:1907-1910.
11. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-1388.
12. Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology 2002;57:2133-2135.
13. Lobo RA. A disorder without identity: "HCA," "PCO," "PCOD," "PCOS," "SLS," What are we to call it? Fertil Steril 1995;63:1158-1160.
14. Herzog AG. Polycystic ovarian syndrome in women with epilepsy: epileptogenic or iatrogenic? Ann Neurol 1996;39:559-560.
15. Herzog AG, Schachter SC. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001;42:311-315.
16. Crowley WF, Filicori M, Spratt DI, Santoro NF. The physiology of gonadotropin-releasing hormone secretion in men and women. Recent Prog Horm Res 1985;41:473-531.
17. McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona sexual experience scale (ASEX): reliability and validity. J Sex Marital Ther 2000;26:25-40.
18. Herzog AG, Coleman AE, Jacobs AR, et al. The relationship of sexual function to the laterality of epileptiform discharges and reproductive hormone levels in women with temporolimbic epilepsy. Epilepsy & Behavior 2003;4:407-413.
19. Santen RJ, Barden CW. Episodic luteinizing hormone secretion in man: pulse analysis, clinical interpretation, and pathological mechanisms. J Clin Invest 1983;72:2031-2040.
20. Veldhuis JD, Johnson ML. Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol 1986;250:E486-E493.
21. Kaada B. Stimulation and regional ablation of the amygdaloid comples with reference to functional representations. In: Eleftheriou BE, ed. The neurobiology of the amgdala. New York: Plenum Press, 1972:205-282.
22. Herzog AG, Russell V, Vaitukaitis JL, Geschwind N. Neuroendocrine dysfunction in temporal lobe epilepsy. Arch Neurol 1982;39:133-135.
23. Drislane FW, Coleman AE, Schomer DL, et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology 1994;44:306-310.
24. Herzog AG, Drislane FW, Schomer DL, et al. Abnormal pulsatile secretion of luteinizing hormone in men with epilepsy: relationship to lateralization of epileptiform discharges. Neurology 1990;40:1557-1561.
25. Rosciszewska D, Buntner B, Guz I, Zawisza L. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry 1986;49:47-51.
26. Murialdo G, Galimberti CA, Gianelli MV, et al. Effects of valproate, phenobarbital and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998;21:52-8.
27. Stoffel-Wagner B, Bauer J, Flugel D, et al. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication. Epilepsia 1998;39:1164-1173.
28. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllyla VV. Menstrual disorders in women with epilepsy receiving carbamazepine. Epilepsia 1995;36:676-681.
29. Klein P, Serje A, Pezzullo JC. Premature ovarian failure in women with epilepsy. Epilepsia 2001;42:1584-1589.
30. Harden CL, Koppel BS, Herzog AG, Nikolov BG, Hauser WA. Seizure frequency is associated with age of menopause in women with epilepsy. Epilepsia (in press).
31. Levesque LA, Herzog AG, Seibel MM. The effect of phenytoin and carbamazepine on dehydroepiandrosterone sulfate in men and women who have partial seizures with temporal lobe involvement. J Clin Endocrinol Metab 1986;63:243-245.
32. SM Paul, Purdy RH. Neuroactive steroids. FASEB J 1992;6:2311-2322.
33. Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986;315:1519-1524.
34. Isojarvi JI, Pakarinen AJ, Myllyla VV. Serum lipid levels during carbamazepine medication: a prospective study. Arch Neurol 1993;50:590-593.
35. Sudhop T, Bauer J, Elger CE, von Bergmann K. Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study. Epilepsia 1999;40:480-484.
36. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-243.
37. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol 1998;49:421-432.
38. Herzog AG. Psychoneuroendocrine aspects of temporolimbic epilepsy (Parts I-III). Psychosomatics 1999;40:95-116.
39. Bear DM, Fedio P. Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977;34:454-467.
40. Altshuler LL, Devinsky O, Post PM, Theodore W. Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Arch Neurol 1990;47:284-288.
41. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000;47:246-249.
42. Zolovick AJ. Effects of lesions and electrical stimulation of the amygdala on hypothalamic-hypophyseal regulation. In: Eleftheriou BE, ed. The neurobiology of the amgdala. New York: Plenum Press, 1972:745-762.
43. Mellanby J, Dwyer J, Hawkins CA, Hitchen C. Effect of experimental limbic epilepsy on the estrus cycle and reproductive success in rats. Epilepsia 1993;34:220-227.
44. Edwards HE, Burnham WM, Ng MM, Asa S, MacLusky NJ. Limbic seizures alter reproductive function in the female rat. Epilepsia 1999;40:1370-1377.
45. Feeney DM, Gullotta FP, Gilmore W. Hyposexuality produced by temporal lobe epilepsy in the cat. Epilepsia 1998;39:140-149.
46. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976;54:321-347.
47. Mattson RH, Kamer JA, Caldwell BV, Cramer JA. Seizure frequency and the menstrual cycle: a clinical study. Epilepsia 1981;22:242.
48. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38:1082-1088.
49. Dreifuss JJ, Murphy JT, Gloor P. Contrasting effects of two identified amygdaloid efferent pathways on single hypothalamic neurons. J Neurophysiol 1968;31:237-248.
50. Renaud LP. Influence of amygdala stimulation on the activity of identified tuberoinfundibular neurons in the rat hypothalamus. J Physiol 1976;260:237-252.
51. Silveira DC, Klein P, Ransil BJ, et al. Lateralized asymmetry in activation of hypothalamic neurons with unilateral amygdaloid seizures. Epilepsia 2000;41:34-41.
52. Amado D, Cavalheiro EA, Bentivoglio M. Epilepsy and hormonal regulation: the patterns of GnRH and galanin immunoreactivity in the hypothalamus of epileptic female rats. Epilepsy Res 1993;14:149-159.
53. Friedman MN, Geula C, Holmes GL, Herzog AG. GnRH-immunoreactive fiber changes with unilateral amygdala-kindled seizures. Epilepsy Res (in press).
54. Parra A, Velasco M, Cervantes C, et al. Plasma prolactin increase following electric stimulation of the amygdala in humans. Neuroendocrinology 1980;31:60-65.
55. Quigg M, Kiely JM, Shneker B, et al. Interictal and postictal alterations of pulsatile secretion of luteinizing hormone in temporal lobe epilepsy in men. Ann Neurol 2002;51:559-566.
56. Gerendai I, Halasz B. Neuroendocrine Asymmetry. Front Neuroendocrinol 1997;18:354-381.
57. Gerendai I, Csaba Z, Voko Z, Csernus V. Involvement of a direct neural mechanism in the control of gonadal functions. J Steroid Biochem Mol Biol 1995;53:299-305.
58. Sanches MA, Domingues R. Differential effects of unilateral lesions in the medial amygdala on spontaneous and induced ovulation. Brain Res Bull 1995;38:313-317.
59. Isojarvi JI. Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy. Epilepsia 1990;31:438-445.
60. Ericsson UB, Bjerre I, Forsgren M, Ivarsson SA. Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine, and valproic acid. Epilepsia 1985;26:594-596.
61. Isojarvi JI, Pakarinen AJ, Myllylla VV. Thyroid function in epileptic patients treated with carbamazepine. Arch Neurol 1989;46:1175-1178.
62. Isojarvi JI, Pakarinen AJ, Myllylla VV. Thyroid function with antiepileptic drugs. Epilepsia 1992;33:142-148.
63. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-1388.
64. Vainionpaa LK, Rattya J, Knip M, et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann Neurol 1999;45:444-450.
65. Stephen LJ, Kwan P, Shapiro D, Dominiczak M, Brodie MJ. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 2001;42:1002-1006.
66. Isojärvi JIT, Rättyä J, Myllylä VV, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446-451.
67. Genton P, Bauer J, Duncan S, et al. On the association between valproate and polycystic ovary syndrome. Epilepsia 2001;42:295-304.
68. Isojarvi JI, Tauboll E, Tapanainen JS, et al. On the association between valproate and polycystic ovary syndrome: a response and an alternative view. Epilepsia 2001;42:305-310.
69. Knockenhauer ES, Key TJ, Kashar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
70. Herzog AG, Seibel MM, Schomer D, Vaitukaitis JL, Geschwind N. Temporal lobe epilepsy: an extrahypothalamic pathogenesis for polycystic ovarian syndrome? Neurology 1984;34:1389-1393.
71. Quigg M, Kiely JM, Shneker B, et al. Interictal and postictal alterations of pulsatile secretion of luteinizing hormone in temporal lobe epilepsy in men. Ann Neurol 2002;51:559-566.
72. Herzog AG. Prolactin: Quo Vadis? Arch Neurol 1992;49:223-224.